首页> 外文期刊>Liver international : >Neutrophil‐to‐lymphocyte ratio is a predictor of early graft dysfunction following living donor liver transplantation
【24h】

Neutrophil‐to‐lymphocyte ratio is a predictor of early graft dysfunction following living donor liver transplantation

机译:中性粒细胞至淋巴细胞比例是活体肝移植后早期移植物功能障碍的预测因子

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Background & Aims Early allograft dysfunction (EAD) is predictive of poor graft and patient survival following living donor liver transplantation (LDLT). Considering the impact of the inflammatory response on graft injury extent following LDLT, we investigated the association between neutrophil‐to‐lymphocyte ratio (NLR) and EAD, 1‐year graft failure, and mortality following LDLT, and compared it to C‐reactive protein (CRP), procalcitonin, platelet‐to‐lymphocyte ratio and the Glasgow prognostic score. Methods A total of 1960 consecutive adult LDLT recipients (1531/429 as development/validation cohort) were retrospectively evaluated. Cut‐offs were derived using the area under the receiver operating characteristic curve (AUROC), and multivariable regression and Cox proportional hazard analyses were performed. Results The risk of EAD increased proportionally with increasing NLR, and the NLR AUROC was 0.73, similar to CRP and procalcitonin and higher than the rest. NLR ?≥? 2.85 (best cut‐off) showed a significantly higher EAD occurrence (20.5% vs 5.8%, P ??0.001), higher 1‐year graft failure (8.2% vs 4.9%, log‐rank P ?=?0.009) and higher 1‐year mortality (7% vs 4.5%, log‐rank P ?=?0.039). NLR?≥?2.85 was an independent predictor of EAD (odds ratio, 1.89 [1.26‐2.84], P ?=?0.002) after multivariable adjustment, whereas CRP and procalcitonin were not. Increasing NLR was independently associated with higher 1‐year graft failure and mortality (both P ??0.001). Consistent results in the validation cohort strengthened the prognostic value of NLR. Conclusions Preoperative NLR ?≥? 2.85 predicted higher risk of EAD, 1‐year graft failure and 1‐year mortality following LDLT, and NLR was superior to other parameters, suggesting that preoperative NLR may be a practical index for predicting graft function following LDLT.
机译:抽象背景&目的早期同种异体移植功能障碍(EAD)是在活体肝移植(LDLT)之后的可移植物和患者存活率的预测性。考虑到炎症反应对LDLT后移植物损伤程度的影响,我们研究了中性粒细胞 - 淋巴细胞比(NLR)和EAD,1年接枝衰竭和LDLT后死亡率之间的关联,并将其与C反应蛋白相比(CRP),ProCalcitonin,血小板到淋巴细胞比率和Glasgow预后得分。方法回顾性评估总共1960个连续的成人LDLT接收者(作为开发/验证队)的1531/429)。使用接收器操作特性曲线(AUROC)下的区域来源截止,并且进行多变量的回归和COX比例危害分析。结果EAD的风险与NLR的增加比例增加,NLR AUROC为0.73,类似于CRP和ProCalcitonin,高于其余。 nlr?≥? 2.85(最佳截止)显示出明显较高的EAD发生(20.5%Vs 5.8%,P≤≤0.001),较高的1年接枝衰竭(8.2%Vs 4.9%,对数级别P?= 0.009)较高的1年死亡率(7%vs 4.5%,log-and等p?= 0.039)。 nlr?≥≤2.85是ead的独立预测因子(多功能比,1.89 [1.26-2.84],多变量调节后,p?= 0.002),而CRP和ProCalcitonin则不是。增加的NLR与较高的1年移植失败和死亡率(P≥≤0.001)独立相关。验证队列的一致结果加强了NLR的预后价值。结论术前NLR?≥? 2.85预测LDLT之后的eAD的较高风险,1年接枝衰竭和1年死亡率,并且NLR优于其他参数,表明术前NLR可以是预测LDLT接枝函数的实用指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号